AstraZeneca vaccine 1 1

AstraZeneca’s Covid vax linked to 30% higher risk to get rare blood clotting

eAwaz Medicine

London (AFP) – A new study, published in the journal BMJ, was the first to compare thrombocytopenia rates between adenovirus and mRNA vaccines — such as Pfizer — across multiple countries. It has found that AstraZeneca’s Covid vaccine is linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab. Several countries …

Dengue

Tropical Disease Dengue

eAwaz Health

London – If someone asked you what the most deadly animal in the world is, you might first think of lions or crocodiles. But—perhaps surprisingly—it’s the mosquito: These tiny insects are responsible for killing over 1 million people each year. Mosquitoes can spread serious diseases, including Zika, malaria, West Nile and dengue, the last of which the World Health Organization (WHO) named a top 10 …

JJs Janssen

J & J’s Covid-19 Vaccine Candidate

eAwaz Medicine

London – Johnson & Johnson is deploying the full strength of its science, scale and expertise to help fight the pandemic as Covid-19 continues to affect people and communities across the world. J&J’s Janssen is using the same technology that it has used in the development of its Ebola vaccine and investigational HIV, RSV and Zika vaccine candidates, which involves using an inactivated common cold …

JJ

Tackling World’s Most Urgent Healthcare Needs

eAwaz Health

London – Championing global health equity, advancing environmental health and empowering its employees to be their best are just some of the ways Johnson & Johnson is working to help improve the well-being of people around the world. The company’s 2021 Health for Humanity Report reveals just how far it’s come toward these ambitious goals. Improving the trajectory of health …

Peripheral Artery Disease

J& J on Amputation Related to Peripheral Artery Disease

eAwaz Medicine

TITUSVILLE – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the launch of Save Legs. Change Lives. Spot Peripheral Artery Disease Now, a multi-year initiative aimed at creating urgency and action to address the hidden threat of peripheral artery disease (PAD)-related amputation, with an initial focus on reaching Black Americans, who are more than twice as likely to be impacted …

JJs Janssen

From Lab to Vaccine Vial: Janssen`s Historic Manufacturing Journey 

eAwaz Medicine

New York – Getting COVID-19 vaccines to people around the world. It’s hard to think of anything else right now, and it’s something that’s been top of mind at Johnson & Johnson since early last year, when the novel coronavirus was just beginning to spread. As Johnson & Johnson begins shipping its Janssen COVID-19 Vaccine this week in the U.S., after …

Vic Fedeli

Strengthening Domestic Pharmaceutical Manufacturing Capacity

eAwaz Local News

Ontario Together Fund continues to support homegrown manufacturing and innovation to provide goods critical to the health, safety, and security of the people of Ontario GUELPH — The Ontario government is supporting an investment of nearly $15 million by Johnson & Johnson Inc., makers of over-the-counter pharmaceuticals for adults and children. The province is investing $2.5 million through the Ontario …

JJ vaccine

EU drug regulator extends J&J vaccine’s shelf life

eAwaz Medicine

EU – The European drug regulator, the European Medicines Agency, has extended the shelf life of Johnson & Johnson’s Covid-19 vaccine to 11 months from 4.5 months, updated product information showed. J&J’s one-shot vaccine can be stored and transported at two to eight degrees Celsius for 11 months. The unopened vials can be stored at minus 25 degrees Celsius to …

Johnson Johnson wants FDA to authorize its Covid 19 vaccine

J&J Vaccine Gets Additional Warning on Bleeding Side Effect

eAwaz Medicine

Washington (Bloomberg) – Johnson & Johnson’s Covid-19 vaccine has been revised by US regulator, Food and Drug Administration, to warn about the risk of a rare bleeding disorder. It told the company an increased risk of immune thrombocytopenia, or ITP, during the 42 days following vaccination can occur. Symptoms include bruising or excessive or unusual bleeding, according to the agency.